Brain Imaging: Volume 165
Published on 31. August 2019
Book
Hardback
441 pages
978-0-12-818361-8 (ISBN)
Description
Brain Imaging, Volume 164, the latest release in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to neuroimaging in aging and neurodegenerative disease. Topics covered in this new release include FTD spectrum, Cerebrovascular disease, HIV, Huntington's Disease, Development of brain PET imaging agents, and Disclosure of imaging biomarker results.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Each volume of Progress in Molecular Biology and Translational Science will be useful for scientists working actively in a field, including those at levels ranging from graduate student to senior investigator. Volumes also are appropriate for new investigators to a field who wish to familiarize themselves with the latest work.
Dimensions
Height: 229 mm
Width: 152 mm
Weight
810 gr
ISBN-13
978-0-12-818361-8 (9780128183618)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Person
David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid ?-protein (Alzheimer's disease) and ?-synuclein (Parkinson's disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Co-Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.
Content
FTD spectrum
Cerebrovascular disease
HIV
Huntington's Disease
Development of brain PET imaging agents
Disclosure of imaging biomarker results
Cerebrovascular disease
HIV
Huntington's Disease
Development of brain PET imaging agents
Disclosure of imaging biomarker results